EV71 vaccine
EV71 vaccine is a biological therapy with 11 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
3
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Long-Term Immunogenicity of Envacgen® in Children
Clinical Trial for Batch Consistency of EV71 Vaccine
A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children
Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine
Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine
Clinical Trials (11)
Long-Term Immunogenicity of Envacgen® in Children
Clinical Trial for Batch Consistency of EV71 Vaccine
A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children
Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine
Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine
Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children
A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71
Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine
The Phase IVd of Inactivated Enterovirus 71 Vaccine
A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine
All 11 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 11